Change of NLRP3 Inflammasome Expression Level, Symptoms, and Functional Status in HFpEF Patients Treated With ARNI
Condition(s):Heart FailureLast Updated:February 17, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Heart FailureLast Updated:February 17, 2020Unknown status
Condition(s):Severe ObesityLast Updated:August 10, 2022Not yet recruiting
Condition(s):Cryopyrin-associated Periodic Syndromes (CAPS); Familial Cold Autoinflam Syn (FCAS); Muckle-wells Syn (MWS); Neonatal Onset Multisystem Inflam Disease (NOMID)Last Updated:March 28, 2016Completed
Condition(s):Inflammasomes; Cognitive Dysfunction; Pyrin Domain-Containing 3 Protein; Postoperative ComplicationsLast Updated:September 1, 2021Completed
Condition(s):Periodontal Diseases; Gingivitis; PeriodontitisLast Updated:October 10, 2023Active, not recruiting
Condition(s):NLRP3; hsCRP; Percutaneous Coronary InterventionLast Updated:February 8, 2023Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:August 1, 2023Not yet recruiting
Condition(s):Lupus Nephritis; SLE NephritisLast Updated:January 25, 2024Recruiting
Condition(s):Inflammatory Response; Extracorporeal Circulation; Complications; Cardiac Surgery; Type 2 DiabetesLast Updated:July 20, 2023Withdrawn
Condition(s):Cryopyrin Associated Periodic SyndromeLast Updated:March 21, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.